Cardio Vascular (OTCBB: CVSL) to Apply for Additional Patents in Europe, Canada and Far East

Ft Lauderdale, Florida 11/24/2009 01:40 AM GMT (TransWorldNews)

Cardio Vascular Medical Device Corp. (CVSL.OB) a leading developer of advanced cardiovascular surgery technology, recently announced that the company's Board of Directors has decided to initiate patent applications in Europe, Canada and the Far East for its proprietary next-generation "steerable guidewire" applicable for all angioplasty procedures.

Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.

Angioplasty is now a common procedure, performed to widen narrow or obstructed blood vessels. It is often performed in place of, or before, more invasive and potentially life-threatening bypass surgery. Heart disease kills over 7 million people worldwide each year and is the leading cause of death for both men and women in the U.S. Angioplasty performed prior to an artery being fully blocked can prevent the onset of heart attacks. Eli Gonen, CEO of Cardio Vascular Medical Device Corp., commented on the importance of the technology in the world market. “Filing these additional patent applications is the first stage in aiding cardiologists in the process of saving lives across the globe. The ability to steer our guidewire during angioplasty procedures using our patented flexi-tip enables more difficult procedures to be completed with greater ease, and speeds overall procedure time. Due to these significant advantages, Cardio Vascular Medical Device’s guidewire has the opportunity to become the guidewire of choice for surgeons throughout the world.”

Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

About Us

Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

Please click here to read the full disclaimer.